Experts discuss future potential of bio pharma in India
Over 100 delegates participate in the conference
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Debating the quality of innovation
In the run up to our 18th Anniversary issue, we ran a poll on our website, with the motion of the house being: The Indian patent…
US FDA approves Synribo for chronic myelogenous leukemia
Synribo blocks certain proteins that promote the development of cancerous cells
Glenmark posts Q2 results, sees growth from US, Indian and Russian markets
Net profit for Q2 was Rs 1567.52million as compared to Rs 782.75 million for the previous quarter
DRL records YoY growth of 27 per cent in Q2 FY13
Revenues from the global generics segment primarily driven by North America, India and other emerging markets
Piramal Enterprises’ Healthcare in alliance with Fujifilm Diosynth Biotechnologies
Will offer the seamless contract development and manufacture of antibody drug conjugates
Venus Remedies bags first Mexican patent for research product
The patent is valid till February 2026
Partnership for TB Care and Control in India invites application for TB Champion AWARD
Award to be given in individual and organisation category